Press "Enter" to skip to content

New patent expiration for Allergan Inc drug DURYSTA

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Inc drug DURYSTA

Annual Drug Patent Expirations for DURYSTA
Annual Drug Patent Expirations for DURYSTA

Durysta is a drug marketed by Allergan Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has one hundred and forty-seven patent family members in thirty-one countries.

The generic ingredient in DURYSTA is bimatoprost. One supplier is listed for this compound. Additional details are available on the bimatoprost profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Inc drug DURYSTA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!